Alzheimer’s disease

Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease

Phase 2 · Enrolling participants

Planned enrollment: 300 participants

Study ages: 55 Years to 80 Years

Recruiting sites listed in: United States

No results-posting date in this record

Phase 3 · Ongoing, no longer enrolling

Planned enrollment: 1,400 participants

Study ages: 55 Years to 80 Years

No results-posting date in this record

Phase 2 · Not yet enrolling

Planned enrollment: 450 participants

Study ages: 50 Years to 90 Years

No results-posting date in this record

A Study to Confirm Safety and Efficacy of Lecanemab in Participants With Early Alzheimer's Disease

Phase 3 · Ongoing, no longer enrolling

Registry enrollment: 1,906 participants

Study ages: 50 Years to 90 Years

No results-posting date in this record

Phase 2 · Enrolling participants

Planned enrollment: 120 participants

Study ages: 55 Years to 90 Years

Recruiting sites listed in: United States

No results-posting date in this record

Phase 1 / Phase 2 · Enrolling participants

Planned enrollment: 36 participants

Study ages: 40 Years to 85 Years

Recruiting sites listed in: United States

No results-posting date in this record